• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.

作者信息

Hudson R J, Thomson I R, Cannon J E, Friesen R M, Meatherall R C

出版信息

Anesthesiology. 1986 Mar;64(3):334-8. doi: 10.1097/00000542-198603000-00006.

DOI:10.1097/00000542-198603000-00006
PMID:3954128
Abstract

The authors determined the pharmacokinetics of fentanyl 100 micrograms X kg-1 iv in patients undergoing elective abdominal aortic surgery. The mean (+/- SD) age of the ten patients was 67.2 +/- 8.7 yr; their mean weight was 78.5 +/- 13.7 kg. Seven patients had aortic aneurysm repair, and the other three patients had aortobifemoral grafts. Serum fentanyl concentrations were determined from samples drawn at increasing intervals over a 24-h period. A three-compartment pharmacokinetic model was fit to the concentration versus time data. Total drug clearance was 9.8 +/- 1.8 ml X min-1 X kg-1. The volume of distribution at steady-state (Vdss) was 5.4 +/- 1.9 X 1 kg-1. Elimination half-time was 8.7 +/- 2.5 h. There were no significant correlations between these pharmacokinetic parameters and patient's age, duration of aortic cross-clamping, duration of surgery, intraoperative blood loss, or volume of iv fluids given intraoperatively. In healthy volunteers or patients undergoing general surgery, other investigators report mean elimination half-times for fentanyl ranging from 1.7 to 4.4 h. The prolonged elimination half-time in patients having abdominal aortic surgery has important clinical implications. In particular, recovery from large doses will take much longer than would have been anticipated from previously published fentanyl pharmacokinetic data.

摘要

相似文献

1
Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.
Anesthesiology. 1986 Mar;64(3):334-8. doi: 10.1097/00000542-198603000-00006.
2
Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery.
Anesthesiology. 1989 Mar;70(3):426-31. doi: 10.1097/00000542-198903000-00011.
3
Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.
Can J Anaesth. 1991 Jan;38(1):61-7. doi: 10.1007/BF03009165.
4
Midazolam pharmacokinetics in patients undergoing abdominal aortic surgery.腹主动脉手术患者的咪达唑仑药代动力学
Anesth Analg. 1994 Aug;79(2):219-25. doi: 10.1213/00000539-199408000-00003.
5
Pharmacokinetics of fentanyl in neonates.芬太尼在新生儿中的药代动力学。
Anesth Analg. 1986 Mar;65(3):227-32.
6
Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age.芬太尼在新生儿和羔羊体内的药代动力学:年龄的影响。
Anesthesiology. 1988 Nov;69(5):683-7. doi: 10.1097/00000542-198811000-00008.
7
Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions.腹主动脉手术患者中丙泊酚和芬太尼的药代动力学与药效学——药效学药物相互作用研究
Biopharm Drug Dispos. 2016 Jul;37(5):252-63. doi: 10.1002/bdd.2009.
8
Fentanyl oxygen anaesthesia for abdominal aortic surgery.芬太尼-氧气麻醉用于腹主动脉手术
Can Anaesth Soc J. 1986 Nov;33(6):719-22. doi: 10.1007/BF03027120.
9
Dose-independent pharmacokinetics of fentanyl.芬太尼的非剂量依赖性药代动力学。
Anesthesiology. 1983 Dec;59(6):537-40. doi: 10.1097/00000542-198312000-00009.
10
Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.大剂量芬太尼的药代动力学。一项针对心脏手术患者的研究。
Br J Anaesth. 1980 Aug;52(8):795-801. doi: 10.1093/bja/52.8.795.

引用本文的文献

1
Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models.使用动态年龄依赖性生理药代动力学模型预测儿科和老年患者中CYP3A4代谢药物的药代动力学
Pharmaceutics. 2025 Feb 7;17(2):214. doi: 10.3390/pharmaceutics17020214.
2
The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.脊髓阿片类药物和齐考诺肽治疗非癌性疼痛的药理学。
Curr Neuropharmacol. 2017;15(2):206-216. doi: 10.2174/1570159x14666160210142339.
3
Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
芬太尼舌下喷雾剂的药代动力学和剂量比例:一项单次 5 交叉研究。
Clin Drug Investig. 2013 Jun;33(6):391-400. doi: 10.1007/s40261-013-0079-8.
4
Multiple peaking phenomena in pharmacokinetic disposition.药代动力学处置中的多重峰现象。
Clin Pharmacokinet. 2010 Jun;49(6):351-77. doi: 10.2165/11319320-000000000-00000.
5
Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.芬太尼口腔崩解片等效剂量与芬太尼药代动力学动静脉差异的比较。
Clin Pharmacokinet. 2006;45(8):843-50. doi: 10.2165/00003088-200645080-00006.
6
Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.芬太尼泡腾颊片在健康志愿者中的药代动力学及剂量比例关系
Clin Pharmacokinet. 2005;44(12):1279-86. doi: 10.2165/00003088-200544120-00006.
7
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.基于生理的药代动力学模型的简化与归并:通过逐步简化模型预测芬太尼和哌替啶在人体内的处置情况
J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):285-307. doi: 10.1023/a:1026194618660.
8
Pharmacokinetics of opioids in liver disease.阿片类药物在肝脏疾病中的药代动力学。
Clin Pharmacokinet. 1999 Jul;37(1):17-40. doi: 10.2165/00003088-199937010-00002.
9
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.阿芬太尼、芬太尼和舒芬太尼的临床药代动力学。最新进展。
Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004.
10
Plasma concentrations of fentanyl in infants, children and adults.婴儿、儿童及成人血浆中芬太尼的浓度。
Can J Anaesth. 1987 Mar;34(2):152-5. doi: 10.1007/BF03015333.